Suppr超能文献

瓜氨酸和精氨酸在治疗线粒体疾病中一氧化氮缺乏的应用。

Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders.

机构信息

Medical Genetics Section, Department of Pediatrics, The Children's Hospital at King Fahad Medical City and King Saud bin Abdulaziz University for Health Science, Riyadh, Kingdom of Saudi Arabia.

出版信息

Mol Genet Metab. 2012 Nov;107(3):247-52. doi: 10.1016/j.ymgme.2012.06.018. Epub 2012 Jul 6.

Abstract

Mitochondrial diseases arise as a result of dysfunction of the respiratory chain, leading to inadequate ATP production required to meet the energy needs of various organs. On the other hand, nitric oxide (NO) deficiency can occur in mitochondrial diseases and potentially play major roles in the pathogenesis of several complications including stroke-like episodes, myopathy, diabetes, and lactic acidosis. NO deficiency in mitochondrial disorders can result from multiple factors including decreased NO production due to endothelial dysfunction, NO sequestration by cytochrome c oxidase, NO shunting into reactive nitrogen species formation, and decreased availability of the NO precursors arginine and citrulline. Arginine and citrulline supplementation can result in increased NO production and hence potentially have therapeutic effects on NO deficiency-related manifestations of mitochondrial diseases. Citrulline is a more efficient NO donor than arginine as it results in a greater increase in de novo arginine synthesis, which plays a major role in driving NO production. This concept is supported by the observation that the three enzymes responsible for recycling citrulline to NO (argininosuccinate synthase and lyase, and nitric oxide synthase) function as a complex that can result in compartmentalizing NO synthesis and channeling citrulline efficiently to NO synthesis. Clinical research evaluating the effect of arginine and citrulline in mitochondrial diseases is limited to uncontrolled open label studies demonstrating that arginine administration to subjects with MELAS syndrome results in improvement in the clinical symptoms associated with stroke-like episodes and a decrease in the frequency and severity of these episodes. Therefore, controlled clinical studies of the effects of arginine or citrulline supplementation on different aspects of mitochondrial diseases are needed to explore the potential therapeutic effects of these NO donors.

摘要

线粒体疾病是由于呼吸链功能障碍导致 ATP 生成不足而引起的,无法满足各器官的能量需求。另一方面,线粒体疾病中可能会出现一氧化氮(NO)缺乏,并可能在多种并发症的发病机制中发挥主要作用,包括类似中风发作、肌病、糖尿病和乳酸性酸中毒。线粒体疾病中 NO 缺乏可能由多种因素引起,包括内皮功能障碍导致的 NO 生成减少、细胞色素 c 氧化酶对 NO 的隔离、NO 分流形成活性氮物种、以及 NO 前体精氨酸和瓜氨酸的可用性降低。精氨酸和瓜氨酸的补充可以增加 NO 的生成,因此可能对线粒体疾病中与 NO 缺乏相关的表现具有治疗作用。瓜氨酸比精氨酸更有效地作为 NO 供体,因为它会导致新合成的精氨酸增加,这对驱动 NO 生成起着重要作用。这一概念得到了以下观察结果的支持,即负责将瓜氨酸再循环生成 NO 的三种酶(精氨酸合成酶和裂解酶、以及一氧化氮合酶)作为一个复合物起作用,可以使 NO 合成的分隔化和瓜氨酸有效地导向 NO 合成。评估精氨酸和瓜氨酸在线粒体疾病中的作用的临床研究仅限于非对照开放标签研究,这些研究表明,MELAS 综合征患者给予精氨酸治疗可改善与类似中风发作相关的临床症状,并减少这些发作的频率和严重程度。因此,需要进行控制良好的临床试验,以研究精氨酸或瓜氨酸补充对线粒体疾病不同方面的影响,从而探索这些 NO 供体的潜在治疗效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验